| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XENT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -$250K | -8.84K | -73.18% | $28.25 | 3.24K | May 13, 2022 | Direct | F1 |
| transaction | XENT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -$91.5K | -3.24K | -100% | $28.25 | 0 | May 13, 2022 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XENT | Stock Option (right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$91K | -3.22K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 3.22K | $28.58 | Direct | F3 |
| transaction | XENT | Stock Option (right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$94.8K | -3.36K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 3.36K | $24.45 | Direct | F3 |
| transaction | XENT | Stock Option (right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$146K | -5.17K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 5.17K | $23.02 | Direct | F3 |
| transaction | XENT | Stock Option (right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$95.8K | -3.39K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 3.39K | $21.00 | Direct | F3 |
| transaction | XENT | Stock Option (right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$162K | -5.73K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 5.73K | $16.50 | Direct | F3 |
| transaction | XENT | Stock Option (right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$273K | -9.67K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 9.67K | $11.84 | Direct | F3 |
| transaction | XENT | Stock Options (Right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$98.1K | -3.47K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 3.47K | $42.05 | Direct | F3 |
| transaction | XENT | Stock Options (Right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$79K | -2.8K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 2.8K | $33.95 | Direct | F3 |
| transaction | XENT | Stock Options (Right to buy) | Disposition pursuant to a tender of shares in a change of control transaction | -$389K | -13.8K | -100% | $28.25 | 0 | May 13, 2022 | Common Stock | 13.8K | $27.55 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]. |
| F2 | Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes. |
| F3 | Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes. |